The serum CXCL10 level in pancreatic cancer patients with lymph node metastasis is significantly higher than that in pancreatic cancer patients without lymph node metastasis (Jiang et al., 2013). This evidence concerns the gene CXCL10 and familial pancreatic carcinoma.